Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

(Reuters) -The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus ...

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...

Washington-based Bornstein Seafoods is recalling 4,550 lbs. of Cooked & Peeled Ready-To-Eat Coldwater Shrimp Meat because of ...

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

This treatment could benefit many different kinds of patients, but doctors will first need to address its unintended ...

The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...

Arcutis Biotherapeutics is a standout in biotech with FDA-approved ZORYVE and strong potential. See why we recommend a buy on ...

Eggs are a hot commodity in U.S. grocery stores at the moment-between egg shortages and recalls, it's left folks concerned ...

The U.S. Food and Drug Administration has approved Moderna’s (MRNA) RSV vaccine, mRESVIA (mRNA-1345), for preventing lower respiratory tract disease in adults aged 18 to 59 who are at higher risk for ...

Some appointees hold some of Kennedy’s more critical views on vaccines, while other picks appear to be olive branches to ...